WO2008073653A3 - Il- 17b for use in wound healing - Google Patents
Il- 17b for use in wound healing Download PDFInfo
- Publication number
- WO2008073653A3 WO2008073653A3 PCT/US2007/084151 US2007084151W WO2008073653A3 WO 2008073653 A3 WO2008073653 A3 WO 2008073653A3 US 2007084151 W US2007084151 W US 2007084151W WO 2008073653 A3 WO2008073653 A3 WO 2008073653A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- wound healing
- pharmaceutical composition
- present
- chondrocytes
- parental
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009536488A JP2010509364A (en) | 2006-11-08 | 2007-11-08 | IL-17B for use in wound healing |
EP07871415A EP2089050A2 (en) | 2006-11-08 | 2007-11-08 | Il- 17b for use in wound healing |
CA002669109A CA2669109A1 (en) | 2006-11-08 | 2007-11-08 | Il-17b for use in wound healing |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86486706P | 2006-11-08 | 2006-11-08 | |
US60/864,867 | 2006-11-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008073653A2 WO2008073653A2 (en) | 2008-06-19 |
WO2008073653A3 true WO2008073653A3 (en) | 2008-08-07 |
Family
ID=39415331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/084151 WO2008073653A2 (en) | 2006-11-08 | 2007-11-08 | Il- 17b for use in wound healing |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2089050A2 (en) |
JP (1) | JP2010509364A (en) |
CA (1) | CA2669109A1 (en) |
WO (1) | WO2008073653A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2736512B1 (en) * | 2011-07-28 | 2021-06-30 | Ian S. Zagon | Methods and compositions for treatment of epithelial wounds |
US20220281967A1 (en) * | 2019-08-02 | 2022-09-08 | Orega Biotech | Novel il-17b antibodies |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998049310A1 (en) * | 1997-04-25 | 1998-11-05 | Zymogenetics, Inc. | Mammalian cytokine-like factor 7 |
WO1999003982A1 (en) * | 1997-07-16 | 1999-01-28 | Human Genome Sciences, Inc. | Interleukin-20 |
WO2000061754A2 (en) * | 1999-04-09 | 2000-10-19 | Curagen Corporation | Human proteins and polynucleotides encoding them |
WO2001046420A2 (en) * | 1999-12-23 | 2001-06-28 | Genentech, Inc. | Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
WO2001064240A2 (en) * | 2000-02-29 | 2001-09-07 | Zymogenetics, Inc. | Methods for promoting production of myelin by schwann cells |
WO2002076386A2 (en) * | 2001-03-26 | 2002-10-03 | Zymogenetics, Inc. | Method of inducing proliferation of retinal stem cells |
US20040248097A1 (en) * | 2003-05-23 | 2004-12-09 | Ming-Shi Chang | Interleukin-20 variants and promoters |
WO2007019453A2 (en) * | 2005-08-04 | 2007-02-15 | Zymogenetics, Inc. | Treatment of wounds using il-17b |
-
2007
- 2007-11-08 JP JP2009536488A patent/JP2010509364A/en active Pending
- 2007-11-08 WO PCT/US2007/084151 patent/WO2008073653A2/en active Application Filing
- 2007-11-08 EP EP07871415A patent/EP2089050A2/en not_active Withdrawn
- 2007-11-08 CA CA002669109A patent/CA2669109A1/en not_active Abandoned
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998049310A1 (en) * | 1997-04-25 | 1998-11-05 | Zymogenetics, Inc. | Mammalian cytokine-like factor 7 |
WO1999003982A1 (en) * | 1997-07-16 | 1999-01-28 | Human Genome Sciences, Inc. | Interleukin-20 |
WO2000061754A2 (en) * | 1999-04-09 | 2000-10-19 | Curagen Corporation | Human proteins and polynucleotides encoding them |
WO2001046420A2 (en) * | 1999-12-23 | 2001-06-28 | Genentech, Inc. | Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
WO2001064240A2 (en) * | 2000-02-29 | 2001-09-07 | Zymogenetics, Inc. | Methods for promoting production of myelin by schwann cells |
WO2002076386A2 (en) * | 2001-03-26 | 2002-10-03 | Zymogenetics, Inc. | Method of inducing proliferation of retinal stem cells |
US20040248097A1 (en) * | 2003-05-23 | 2004-12-09 | Ming-Shi Chang | Interleukin-20 variants and promoters |
WO2007019453A2 (en) * | 2005-08-04 | 2007-02-15 | Zymogenetics, Inc. | Treatment of wounds using il-17b |
Non-Patent Citations (1)
Title |
---|
DATABASE UniProt [online] EBI; 19 July 2005 (2005-07-19), XP002413790, Database accession no. Q9UHF5 * |
Also Published As
Publication number | Publication date |
---|---|
JP2010509364A (en) | 2010-03-25 |
WO2008073653A2 (en) | 2008-06-19 |
CA2669109A1 (en) | 2008-06-19 |
EP2089050A2 (en) | 2009-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009040420A3 (en) | Use of a monoterpene to increase tissue repair | |
NZ606825A (en) | Methods and compositions for treating complement-associated disorders | |
WO2007002390A3 (en) | Compositions and methods for modulation of smn2 splicing | |
TW200806318A (en) | Uses of anti-insulin-like growth factor I receptor antibodies | |
WO2005094553A3 (en) | Compositions for promoting bone growth and methods thereof | |
NZ602861A (en) | Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries | |
EP1143943A3 (en) | P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant | |
WO2015009991A8 (en) | Methods, systems, and compositions for promoting bone growth | |
WO2009158480A3 (en) | Stimulation of cartilage formation using reduced pressure treatment and chondrocytes | |
MX2010009623A (en) | 1-benzyl-3-hydroxymethylindazoiî¹e derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1. | |
WO2009154840A3 (en) | Compositions and methods using stem cells in cutaneous wound healing | |
WO2009048778A3 (en) | Laminins, derivatives, and compositions including same and method for their therapeutic use | |
WO2008045559A3 (en) | Methods of treating oral mucositis | |
WO2009079451A3 (en) | Compositions and methods of promoting wound healing | |
MX2010009625A (en) | 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40. | |
WO2007112453A3 (en) | Methods amd compositions for treating conditions | |
WO2009022338A3 (en) | Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications | |
EP2316941A3 (en) | Compositions and their uses directed to IL-4R alpha | |
EP2407147A3 (en) | Composition with bio-rigenerative, restorative and eutrophying activity | |
EP3305305A3 (en) | Silicate containing compositions and methods of treatment | |
HK1106253A1 (en) | Desoxo-nonadepsipeptides | |
EP1844779A3 (en) | Tergurid/protergurid for treating chronic pain (e.g. migraine) | |
WO2007019453A3 (en) | Treatment of wounds using il-17b | |
WO2006078713A3 (en) | Methotrexate combinations for treating inflammatory diseases | |
WO2008073653A3 (en) | Il- 17b for use in wound healing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07871415 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 2009536488 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2669109 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007871415 Country of ref document: EP |